Corporate reputation study by PatientView, 2016 Study on the corporate reputation of the pharmaceutical industry in 2016—from the perspective of patient groups
For the attention of: all health campaignersWe value your feedback!Dear health campaigner To thank you for your participation in this study, all respondents will get a final copy of the resulting report (if they wish). As an active patient-group representative, your opinion is very important - particularly on issues around patient-group and pharma relations. We would like to get your feedback on the behaviour of pharma, and how they can improve.
This study has already been performed for five years in a row, ever since 2011, giving a good overview of the developments of corporate reputation of the pharma industry and what matters to patients. The results of the study are highly appreciated by the pharma industry, allowing them to learn about the views of patient groups and so adapt their policies to be genuinely more patient centric. To be sure that your response is made in time, please complete before Monday, 6th February 2017. If you would like a copy of any of last year's (2015) reports about the corporate reputation of pharma, please email: alexwyke@patient-view.com Alternatively, you can find out more about the corporate reputation series of reports on PatientView's website (address at the end of this email). Thank you in anticipation, Alexandra Wyke, CEO, PatientView |